McDonald 2022
|
Canada
|
Cluster RCT
|
Acute care
|
Clinician, patient
|
To evaluate the effect of an electronic deprescribing decision support
tool on
adverse drug events after hospital discharge among older adults with
polypharmacy
|
6,633 participants ≥65 years, taking ≥5 regular medications for any
conditions, including gabapentinoids prior to hospital admission
|
Kasper
2014
|
Multiplea
|
RCT
|
Not reportedb
|
Patient
|
To evaluate the frequency
and severity of discontinuation and rebound symptoms associated with
pregabalin in patients with moderate-to-severe Generalised Anxiety
Disorder
|
615 participants 18 to 65 years with a primary diagnosis of Generalised
Anxiety Disorder
|
Chazot
2021c
|
United Kingdom
|
Observational
|
Primary care
|
Clinician, patient
|
To validate the efficacy of the Gabapentinoids and Opioids Tapering
Toolbox (GOTT)
|
Clinicians who prescribe gabapentinoids (and opioid analgesics)
|
Collinson 2019c
|
United Kingdom |
Observational |
Primary care |
Clinician |
To reduce gabapentinoid prescribing at the
Haworth Medical Practice by 10% in one year |
Any patient prescribed
regular gabapentinoids for any condition |